Dec. 23 (UPI) -- President Joe Biden on Thursday signed a bill that aims to expand funding for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
The Accelerating Access to Critical Therapies for ALS makes $100 million available per year between 2022 and 2026. The legislation is expected to build new pathways to funding early access to ALS investigational therapies.